Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
9.92
-0.51 (-4.89%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $703.41 million as of October 30, 2026. It is the 12,063rd most valuable company in the world and the 2,486th biggest in the United States. Its market cap has increased by 159.65% in one year.
Market Cap
703.41M
Enterprise Value
447.79M
1-Year Change
159.65%
Global Rank
Country Rank
#2,486 United States
Category
ChartMarket Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $703.41M, an increase of 98.26%. That is a compound annual growth rate of 23.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 703.41M | 265.36% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 754.88M |
| OmniAb | 745.35M |
| ArriVent BioPharma | 733.21M |
| Wave Life Sciences | 708.05M |
| Achieve Life Sciences | 702.82M |
| Attovia Therapeutics | 693.44M |
| SL Science Holding | 684.32M |
| Apnimed | 682.74M |